Ad is loading...
NKTR
Price
$1.06
Change
+$0.05 (+4.95%)
Updated
Nov 22, 03:30 PM (EDT)
97 days until earnings call
SLS
Price
$1.21
Change
-$0.01 (-0.82%)
Updated
Nov 22, 03:36 PM (EDT)
118 days until earnings call
Ad is loading...

NKTR vs SLS

Header iconNKTR vs SLS Comparison
Open Charts NKTR vs SLSBanner chart's image
Nektar Therapeutics
Price$1.06
Change+$0.05 (+4.95%)
Volume$100
CapitalizationN/A
SELLAS Life Sciences Group
Price$1.21
Change-$0.01 (-0.82%)
Volume$500
CapitalizationN/A
NKTR vs SLS Comparison Chart
Loading...
NKTR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SLS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
NKTR vs. SLS commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NKTR is a Hold and SLS is a StrongSell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (NKTR: $1.01 vs. SLS: $1.22)
Brand notoriety: NKTR: Notable vs. SLS: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NKTR: 98% vs. SLS: 120%
Market capitalization -- NKTR: $186.3M vs. SLS: $85.87M
NKTR [@Biotechnology] is valued at $186.3M. SLS’s [@Biotechnology] market capitalization is $85.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NKTR’s FA Score shows that 0 FA rating(s) are green whileSLS’s FA Score has 0 green FA rating(s).

  • NKTR’s FA Score: 0 green, 5 red.
  • SLS’s FA Score: 0 green, 5 red.
According to our system of comparison, both NKTR and SLS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NKTR’s TA Score shows that 4 TA indicator(s) are bullish while SLS’s TA Score has 5 bullish TA indicator(s).

  • NKTR’s TA Score: 4 bullish, 6 bearish.
  • SLS’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, SLS is a better buy in the short-term than NKTR.

Price Growth

NKTR (@Biotechnology) experienced а -13.68% price change this week, while SLS (@Biotechnology) price change was -3.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.98%, and the average quarterly price growth was +4.00%.

Reported Earning Dates

NKTR is expected to report earnings on Feb 27, 2025.

SLS is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NKTR($186M) has a higher market cap than SLS($85.9M). NKTR YTD gains are higher at: 78.761 vs. SLS (15.094). SLS has higher annual earnings (EBITDA): -32.77M vs. NKTR (-137.77M). NKTR has more cash in the bank: 244M vs. SLS (21M). SLS has less debt than NKTR: SLS (576K) vs NKTR (108M). NKTR has higher revenues than SLS: NKTR (93.1M) vs SLS (0).
NKTRSLSNKTR / SLS
Capitalization186M85.9M217%
EBITDA-137.77M-32.77M420%
Gain YTD78.76115.094522%
P/E RatioN/AN/A-
Revenue93.1M0-
Total Cash244M21M1,162%
Total Debt108M576K18,750%
FUNDAMENTALS RATINGS
NKTR vs SLS: Fundamental Ratings
NKTR
SLS
OUTLOOK RATING
1..100
5712
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
6253
P/E GROWTH RATING
1..100
88100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SLS's Valuation (57) in the Biotechnology industry is in the same range as NKTR (63). This means that SLS’s stock grew similarly to NKTR’s over the last 12 months.

SLS's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as NKTR (100). This means that SLS’s stock grew similarly to NKTR’s over the last 12 months.

NKTR's SMR Rating (99) in the Biotechnology industry is in the same range as SLS (100). This means that NKTR’s stock grew similarly to SLS’s over the last 12 months.

SLS's Price Growth Rating (53) in the Biotechnology industry is in the same range as NKTR (62). This means that SLS’s stock grew similarly to NKTR’s over the last 12 months.

NKTR's P/E Growth Rating (88) in the Biotechnology industry is in the same range as SLS (100). This means that NKTR’s stock grew similarly to SLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NKTRSLS
RSI
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 18 days ago
76%
Bullish Trend 11 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
NKTR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SLS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARTSX38.180.76
+2.03%
Artisan Small Cap Investor
FCNAX47.360.12
+0.25%
Fidelity Advisor Consumer Discret A
FIKMX12.150.01
+0.08%
Fidelity Advisor Real Estate Income Z
RCEAX8.96N/A
N/A
RBC China Equity A
MSAUX21.65-0.18
-0.82%
Morgan Stanley Inst Asia Opp A

NKTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTR has been loosely correlated with NTLA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTR jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTR
1D Price
Change %
NKTR100%
+1.00%
NTLA - NKTR
43%
Loosely correlated
+5.18%
SLS - NKTR
42%
Loosely correlated
-1.61%
DNLI - NKTR
41%
Loosely correlated
-0.82%
MDGL - NKTR
38%
Loosely correlated
+3.83%
INKT - NKTR
36%
Loosely correlated
-2.11%
More

SLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLS has been loosely correlated with FULC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SLS jumps, then FULC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLS
1D Price
Change %
SLS100%
-1.61%
FULC - SLS
48%
Loosely correlated
-0.67%
NKTR - SLS
42%
Loosely correlated
+1.00%
SNPX - SLS
34%
Loosely correlated
-3.24%
AXON - SLS
32%
Poorly correlated
+3.52%
MDGL - SLS
30%
Poorly correlated
+3.83%
More